Brain tumors manifest as abnormal growths within the brain or its surrounding structures, potentially arising from diverse cell types like glial cells, neurons, or meninges. These growths can be categorized as either benign or malignant, with the latter having the capacity to infiltrate neighboring tissues and metastasize. Symptoms vary widely based on factors such as tumor size, location, and growth rate. Common manifestations encompass persistent headaches, seizures, alterations in vision or hearing, cognitive decline, and shifts in personality. Diagnosis typically entails a blend of imaging modalities like magnetic resonance imaging (MRI) or computed tomography (CT) scans, followed by biopsy for precise classification and grading. Treatment strategies hinge on variables such as tumor location, size, grade, and patient health status and preferences. Options may encompass surgical excision, radiation therapy, chemotherapy, targeted drug therapy, or a combination thereof. Supportive measures, including steroid administration or anticonvulsants, are sometimes employed to alleviate symptoms and enhance quality of life.
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)